Author(s):
Soumya M, R Deepa
Email(s):
deepamaheswari78@gmail.com
DOI:
10.5958/2454-2660.2021.00032.6 
Address:
Soumya M, Mrs. R Deepa
Lecturer and Associate Professor, Department of Medical Surgical Nursing, College of Nursing, SRIPMS, Coimbatore, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 9,
Issue - 1,
Year - 2021
ABSTRACT:
Herd immunity is renowned as Herd effect. It is community or group protection that happens when a critical number of the population is immune to certain disease. Acquired immunity is established at the level of the individual, either through natural infection with a pathogen or through immunization with a vaccine. Herd immunity stems from the effects of individual immunity scaled to the level of the population. It refers to the indirect protection from infection conferred to susceptible individuals when a sufficiently large proportion of immune individuals exist in a population. This population-level effect is often considered in the context of vaccination programs, which aim to establish herd immunity so that those who cannot be vaccinated, including the very young and immunocompromised, are still protected against disease. We can get natural immunity by contracting the illness and building an immune response to it.
Cite this article:
Soumya M, R Deepa. Herd Immunity. Int. J. Nur. Edu. and Research. 2021; 9(1):125-127. doi: 10.5958/2454-2660.2021.00032.6
Cite(Electronic):
Soumya M, R Deepa. Herd Immunity. Int. J. Nur. Edu. and Research. 2021; 9(1):125-127. doi: 10.5958/2454-2660.2021.00032.6 Available on: https://ijneronline.com/AbstractView.aspx?PID=2021-9-1-32
REFERENCE:
1. https://jamanetwork.com/ on 10/29/2020
2. John TJ. Samuel R (2000). “Herd immunity and herd effect: new insights and definitions”. Eur J Epidemiol. 16(7):601-6.
3. Fox JP, Elveback L, Scott W, Gatewood L, Ackerman E (1995). Herd immunity: basic concept and relevance to public health immunization practices. Am J Epidemiol. 141(3):187-97.
4. Peter GS (2010). “Concepts of herd protection and immunity”. Procedia in Vaccinology 2. 134–139. Available online at: www.sciencedirect.com.
5. https://academic.oup.com/cid/article/52/7/911/299077 by guest on 29 October 2020
6. Topley, W. W. C.; Wilson, G. S. (May 1923). "The Spread of Bacterial Infection. The Problem of Herd-Immunity". The Journal of Hygiene. 21 (3): 243–49. doi:10.1017/s0022172400031478. PMC 2167341. PMID 20474777.
7. Hedrich, A. W. (1933). Monthly Estimates of the Child Population Susceptible to Measles, 1900–1931, Baltimore, Md. American Journal of Epidemiology, 17(3), 613–636.
8. Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1 May 2004). "Evolution of measles elimination strategies in the United States". The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084. Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (March 1967). "Epidemiologic basis for eradication of measles in 1967". Public Health Reports. 82 (3): 253–56. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.
9. Fine, P.; Eames, K.; Heymann, D. L. (1 April 2011). "'Herd immunity': A rough guide". Clinical Infectious Diseases. 52 (7): 911–16. doi:10.1093/cid/cir007. PMID 21427399.
10. Strassburg, M. A. (1982). "The global eradication of smallpox". American Journal of Infection Control. 10 (2): 53–59. doi:10.1016/0196-6553(82)90003-7. PMID 7044193
11. Bull, R. A.; White, P. A. (2011). "Mechanisms of GII.4 norovirus evolution". Trends in Microbiology. 19 (5): 233–40. doi:10.1016/j.tim.2011.01.002. PMID 21310617
12. McEllistrem, M. C.; Nahm, M. H. (2012). "Novel pneumococcal serotypes 6C and 6D: Anomaly or harbinger". Clinical Infectious Diseases. 55 (10): 1379–86. doi:10.1093/cid/cis691. PMC 3478140. PMID 22903767